| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Guardant Health, Inc. (GH) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 73 sells. GH is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.03M | $261.30M | -100,000 | |
| Other | 79.1K | $10.19M | - | |
| CFO | 47.5K | $6.12M | -2,000 | |
| Other | 46.7K | $6.02M | - | |
| Other | 36.0K | $4.63M | -10,000 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 26, 2021 | Clark Ian T66 | Director | Sale+OE | 538 | $159.92 | $86,036.96 | -10.4% | -32.5% | -60.1% | |
| Apr 26, 2021 | Eltoukhy Helmy76 | Chief Executive Officer | Sell | 8,139 | $160.11 | $1,303,160.22 | -0.2% | -32.5% | -60.1% | |
| Apr 21, 2021 | Eltoukhy Helmy76 | Chief Executive Officer | Sell | 72,365 | $151.53 | $10,965,690.24 | -0.3% | -23.4% | -56.9% | |
| Apr 19, 2021 | Eltoukhy Helmy76 | Chief Executive Officer | Sell | 259,162 | $157.60 | $40,842,730.50 | -0.8% | -23.6% | -52.3% | |
| Apr 14, 2021 | Eltoukhy Helmy76 | Chief Executive Officer | Sell | 239,649 | $156.02 | $37,391,165.00 | -0.7% | -21.9% | -53.6% | |
| Apr 12, 2021 | Meresman Stanley J75 | Director | Sale+OE | 4,934 | $153.74 | $758,532.89 | -15.1% | -20.3% | -54.1% | |
| Apr 9, 2021 | Eltoukhy Helmy76 | Chief Executive Officer | Sell | 220,685 | $159.33 | $35,162,548.13 | -0.6% | -23.0% | -53.1% | |
| Apr 5, 2021 | Kaul Samir | Director | Sell | 5,000 | $158.56 | $792,788.55 | -4.3% | -21.8% | -52.8% | |
| Mar 25, 2021 | Clark Ian T66 | Director | Sale+OE | 538 | $132.09 | $71,064.42 | -10.4% | -5.1% | -55.9% | |
| Mar 10, 2021 | Meresman Stanley J75 | Director | Sale+OE | 4,934 | $137.85 | $680,151.90 | -54.9% | -21.1% | -59.7% |